The way Infleqtion’s stock has fluctuated over the past few weeks is almost theatrical. INFQ closed at $16.35 on a Friday in late May, up over 11% for the day and about 41% for the week. The chart resembled an escaped elevator. The peculiar thing is that practically none of it was related to the company’s actual sales growth.
A letter was what made a difference. Not a wire transfer, not a contract, not a completed transaction. The U.S. Commerce Department sent a letter of intent indicating that Infleqtion would be one of nine quantum computing companies to receive approximately two billion dollars in federal incentives. If everything goes according to plan, Inflection’s share under the CHIPS and Science Act would be about $100 million. That’s not good news for a business that made $9.46 million in revenue last quarter but lost over $30 million during that same period. That is a completely different weight class.
The figures reveal a complex narrative. With only about $27 million in total liabilities, Inflection has about $443 million in cash and short-term investments. Therefore, this is not a company that is struggling. It is a research-stage company that has enough runway to continue burning money for a long time while working on a project known as a single neutral-atom platform. However, the revenue is very small. The losses are actual. Nearly all of the valuation, which is more than $3.5 billion in market capitalization, is based on potential future developments.
Here, it’s difficult to ignore the pattern. More than ten years ago, skeptics mocked a car company that couldn’t make a profit, and Tesla faced similar doubts. More recently, Rivian has made its own version of this claim. However, quantum computing is in a different and unfamiliar place; it has been researched in labs for decades without yielding a clear commercial product. It has been probed by hundreds of academic institutions and corporate labs. It hasn’t been cracked open yet. Some investors are wary because of that history. Others see precisely what they want in terms of moonshot odds.
The mood was aptly captured by the market on May 22. With a volume of almost 66 million shares, or about seven times its average, INFQ began at $15.90, rose as high as $18.20, and ended at $16.35. Before sellers intervened, premarket trading reportedly saw a 35% increase. Alongside it, other quantum names surged: IonQ gained about eight percent, D-Wave gained over fourteen, and Rigetti increased by almost twenty percent. The entire neighborhood is thrilled when Washington selects the winners.

Matt Kinsella, CEO of Infleqtion, referred to quantum computing as a “foundational technology” for both national security and economic competitiveness. Perhaps predictable framing, but that’s also what the government appears to think. According to reports, Commerce will purchase $100 million worth of Infleqtion common stock at a fifteen percent discount to market as part of the proposed deal. This minority equity stake would further entangle Washington in the company’s destiny.
There is, however, a hitch that is worth clinging to. A letter of intent is not equivalent to cash. It serves as a starting point for negotiations, subject to final signoff, technical milestones, and due diligence. The sentiment that boosted INFQ so quickly could be depleted equally quickly if any of those steps stall. The rhythm is familiar to anyone who has witnessed momentum stocks ride headlines into orbit before returning to the ground.
On Monday, markets were closed in observance of Memorial Day. When traders return on Tuesday and begin to ask the obvious question, “Now what?” that will be the next real test of whether this rally has lasting power. It’s possible that Inflection develops into the position Washington appears prepared to assign it. It’s also possible that quantum computing will remain an exciting concept that refuses to be commercialized for ten more years. As you watch this develop, you get the impression that the market hasn’t made a decision yet, which might be the most truthful aspect of INFQ at the moment.
